Paper
(E)-8-(4-(Benzyloxy)benzylidene)-4-(4-(benzyloxy)phenyl)-
RSC Advances
158.3, 159.2, 160.3, 160.5, 162.9; MS (EI): m/z ¼ 43 (35), 65 (21),
91 (60), 119 (100), 138 (61), 239 (10), 256 (75), 449 (5).
5,6,7,8-tetrahydro-6-methyl-2-phenylpyrido[4,3-d]pyrimidine
(3b). IR (KBr, cmꢀ1) nmax: 3034, 2931, 1611, 1504; 1H NMR (300
MHz, DMSO-d6): 2.34 (3H, s, N–CH3), 3.67 (2H, s, N–CH2), 3.70
(2H, s, N–CH2), 5.15 (2H, s, O–CH2), 5.19 (2H, s, O–CH2), 7.10
(2H, d, J ¼ 8.4 Hz), 7.16 (2H, d, J ¼ 8.4 Hz), 7.34–7.53 (15H, m),
7.71 (2H, d, J ¼ 8.4 Hz), 8.3 (1H, s, C]CH), 8.53–8.56 (2H, m);
13C NMR (75 MHz, DMSO-d6): 45.1, 55.6, 69.2, 69.3, 114.6, 114.9,
122.3, 127.7, 127.8, 128.3, 128.4, 128.5, 129.7, 129.9, 130.4,
130.6, 131.6, 136.7, 136.8, 137.6, 158.2, 159.5, 160.3, 162.8; MS
(EI): m/z ¼ 42 (5), 65 (22), 91 (100), 168 (10), 314 (16), 404 (74),
510 (97), 601 (23).
(E)-8-(3-Bromobenzylidene)-4-(3-bromophenyl)-5,6,7,8-tetra-
hydro-6-methyl-2-phenylpyrido[4,3-d]pyrimidine (3c). 1H NMR
(300 MHz, DMSO-d6): 2.34 (3H, s, N–CH3), 3.66 (2H, s, N–CH2),
3.71 (2H, s, N–CH2), 7.43–7.59 (7H, m), 7.71–7.77 (3H, m), 7.92
(1H, s), 5.34 (1H, s), 8.56–8.57 (2H, m); MS (EI): m/z ¼ 42 (22),
114 (20), 142 (41), 181 (24), 240 (21), 378 (82), 547 (100).
(E)-8-Benzylidene-5,6,7,8-tetrahydro-6-methyl-2,4-diphe-
nylpyrido[4,3-d]pyrimidine (3d). 1H NMR (300 MHz, DMSO-d6):
2.34 (3H, s, N–CH3), 3.68 (2H, s, N–CH2), 3.74 (2H, s, N–CH2),
7.36–7.55 (11H, m), 7.73–7.74 (2H, d, J ¼ 3.7 Hz), 8.38 (1H, s, C]
CH), 8.54–8.55 (2H, m); 13C NMR (75 MHz, DMSO-d6): 45.1,
54.5, 55.4, 123.0, 127.7, 128.1, 128.4, 128.6, 128.9, 129.0, 129.7,
129.9, 130.5, 131.8, 135.6, 137.2, 137.4, 158.1, 160.5, 163.7; MS
(EI): m/z ¼ 57 (67), 77 (95), 115 (100), 142 (42), 167 (21), 298 (37),
389 (52).
(E)-8-(2,4-Dichlorobenzylidene)-4-(2,4-dichlorophenyl)-5,6,7,8-
tetrahydro-6-methyl-2-phenylpyrido[4,3-d]pyrimidine (3e). IR
(KBr, cmꢀ1) nmax: 2947, 1596, 1540, 1463; 1H NMR (300 MHz,
DMSO-d6): 2.28 (3H, s, N–CH3), 3.55 (2H, s, N–CH2), 3.58 (2H, s,
N–CH2), 7.47–7.69 (6H, m), 7.77–7.79 (1H, m), 7.87 (1H, d, J ¼ 1.5
Hz), 8.37 (1H, s, C]CH), 8.40–8.43 (3H, m); 13C NMR (75 MHz,
DMSO-d6): 44.9, 53.2, 124.3, 127.5, 127.7, 127.9, 128.7, 129.1,
129.3, 130.9, 132.1, 132.2, 132.7, 133.6, 133.8, 134.4, 134.5, 134.8,
136.8, 157.2; MS (EI): m/z ¼ 42 (63), 149 (90), 178 (37), 212 (47),
240 (62), 268 (30), 319 (44), 353 (100), 392 (91), 492 (21), 527 (12).
(E)-8-(4-Chlorobenzylidene)-4-(4-chlorophenyl)-5,6,7,8-tetra-
hydro-6-methyl-2-phenylpyrido[4,3-d]pyrimidine (3f). IR (KBr,
cmꢀ1) nmax: 2947, 1596, 1534, 1488; 1H NMR (300 MHz; DMSO-
d6): 2.34 (3H, s, N–CH3), 3.68 (2H, s, N–CH2), 3.71 (2H, s, N–
CH2), 7.54–7.58 (7H, m), 7.63 (2H, d, J ¼ 8.3 Hz), 7.78 (2H, d, J ¼
8.3 Hz), 8.35 (1H, s, C]CH), 8.55 (2H, m); 13C NMR (75 MHz,
DMSO-d6): 45.0, 123.2, 127.7, 127.9, 128.6, 130.9, 131.6, 132.5,
132.8, 134.5, 134.7, 135.9, 137.2, 158.1, 160.6, 162.5; MS (EI): m/z
¼ 42 (30), 91 (33), 139 (49), 260 (51), 332 (100), 415 (21), 457 (88),
458 (78).
(8E)-8-(4-Methylbenzylidene)-4-(4-methylphenyl)-2,3,5,6,7,8-
hexahydro-6-methyl-2-phenylpyrido[4,3-d]pyrimidine (3h). IR
(KBr, cmꢀ1) nmax: 3275, 2788, 1591, 1555; H NMR (300 MHz,
1
DMSO-d6): 2.16 (3H, s, N–CH3), 2.27 (3H, s, CH3), 2.29 (3H, s,
CH3), 2.62 (1H, d, J ¼ 16.4 Hz, N–CH), 2.95 (1H, d, J ¼ 16.5 Hz,
N–CH), 3.25 (1H, d, J ¼ 13.9 Hz, N–CH), 3.45 (1H, d, J ¼ 13.9 Hz,
N–CH), 5.07 (1H, s), 7.14–7.16 (6H, m), 7.21 (2H, d, J ¼ 8.0 Hz),
7.41–7.44 (4H, m), 7.93–7.96 (2H, m), 8.15 (1H d, J ¼ 1.5 Hz); 13
C
NMR (75 MHz, DMSO-d6): 18.5, 20.7, 20.8, 45.2, 55.2, 55.8,
113.9, 121.7, 126.5, 126.7, 128.1, 128.8, 129.1, 132.5, 133.5,
134.5, 135.1, 135.4, 136.8, 142.2, 151.5; MS (EI): m/z ¼ 42 (10),
104 (18), 207 (32), 299 (100), 328 (27), 375 (15), 419 (64).
(8E)-8-(2,4-Dichlorobenzylidene)-4-(2,4-dichlorophenyl)-
2,3,5,6,7,8-hexahydro-6-methyl-2-phenylpyrido[4,3-d]pyrimi-
1
dine (3i). IR (KBr, cmꢀ1) nmax: 3234, 3075, 1617, 1550; H NMR
(300 MHz; DMSO-d6): 2.14 (3H, s, N–CH3), 2.64 (1H, d, J ¼ 16.5
Hz, N–CH), 3.00 (1H, d, J ¼ 16.5 Hz, N–CH), 3.18 (1H, d, J ¼ 13.8
Hz, N–CH), 3.30 (1H, d, J ¼ 13.8 Hz, N–CH), 5.65 (1H, s), 7.28
(1H, d, J ¼ 8.5 Hz), 7.38–7.52 (7H, m), 7.60 (1H, d, J ¼ 8.5 Hz),
7.63 (1H, s), 7.90–7.93 (2H, m), 8.30 (1H, s). 13C NMR (75 MHz,
DMSO-d6): 44.9, 52.4, 54.4, 56.0, 114.3, 118.2, 126.7, 127.0,
128.2, 128.6, 128.7, 130.4, 131.3, 131.8, 133.0, 133.8, 133.9,
134.3, 134.7, 135.1, 141.2, 152; MS (EI): m/z ¼ 42 (10), 77 (14),
104 (22), 299 (30), 319 (51), 353 (100), 382 (11), 417 (10), 529 (17).
(8E)-8-(2,3-Dichlorobenzylidene)-4-(2,3-dichlorophenyl)-
2,3,5,6,7,8-hexahydro-6-methyl-2-phenylpyrido[4,3-d]pyrimi-
1
dine (3j). IR (KBr, cmꢀ1) nmax: 3234, 3075, 1617, 1550; H NMR
(300 MHz; DMSO-d6): 2.14 (3H, s, N–CH3), 2.64 (1H, d, J ¼ 16.8
Hz, N–CH), 3.03 (1H, d, J ¼ 16.8 Hz, N–CH), 3.30 (1H, d, J ¼ 13.8
Hz, N–CH), 3.4 (1H, d, J ¼ 14.3 Hz, N–CH), 4.36 (1H, s), 5.75 (1H,
s), 7.24 (1H, d, J ¼ 7.6 Hz), 7.31–7.57 (8H, m), 7.92 (2H, d, J ¼ 5.6
Hz), 8.32 (1H, s); 13C NMR (75 MHz, DMSO-d6): 44.9, 53.7, 54.4,
56.0, 114.4, 119.3, 126.7, 127.7, 128.2, 128.5, 128.6, 129.2, 129.3,
128.8, 130.4, 130.7, 131.8, 131.9, 134.0, 134.7, 135.1, 137.9,
144.6, 152.1; MS (EI): m/z ¼ 42 (10), 77 (14), 104 (22), 299 (30),
319 (51), 353 (100), 382 (11), 417 (10), 529 (17).
Acknowledgements
We gratefully acknowledge the support of this work by Drug
Applied Research Center, Tabriz University of Medical Sciences,
Iran.
References
1 J. Deutsch, H. A. Prescott, D. Muller, E. Kemnitz and
H. Lieske, J. Catal., 2005, 231, 269–278.
2 D. Zhao, Q. Huo, J. Feng, B. F. Chmelka and G. D. Stucky,
J. Am. Chem. Soc., 1998, 120, 6024–6036.
3 W. Zhang, T. R. Pauly and T. J. Pinnavaia, Chem. Mater., 1997,
9, 2491–2498.
4 A. Galarneau, D. Desplantier-Giscard, F. Di Renzo and
F. Fajula, Catal. Today, 2001, 68, 191–200.
(E)-8-(4-Methoxybenzylidene)-5,6,7,8-tetrahydro-4-(4-methox-
yphenyl)-6-methyl-2-phenylpyrido[4,3-d]pyrimidine (3g). IR
1
(KBr, cmꢀ1) nmax: 2921, 1606, 1534, 1499; H NMR (300 MHz,
DMSO-d6): 2.35 (3H, s, N–CH3), 3.68 (2H, s, N–CH2), 3.71 (2H, s,
N–CH2), 3.80 (3H, s, O–CH3), 3.84 (3H, s, O–CH3), 7.04 (2H, d, J ¼
8.5 Hz), 7.10 (2H, d, J ¼ 8.5 Hz), 7.48 (2H, d, J ¼ 8.5 Hz), 7.52–7.53
(3H, m), 7.02 (2H, d, J ¼ 8.5 Hz), 8.30 (1H, s, C]CH), 8.53–8.55
(2H, m); 13C NMR (75 MHz, DMSO-d6): 45.2, 55.2, 55.3, 113.8,
114.1, 122.3, 127.7, 128.2, 128.5, 129.9, 130.4, 130.7, 131.6, 137.6,
5 V. Y. Gusev, X. Feng, Z. Bu, G. L. Haller and J. A. O'Brien,
J. Phys. Chem., 1996, 100, 1985–1988.
This journal is © The Royal Society of Chemistry 2014
RSC Adv., 2014, 4, 18117–18126 | 18125